Sex and Iron Modify Fibroblast Growth Factor 23 Concentration in 1-Year-Old Children

J Clin Endocrinol Metab. 2017 Dec 1;102(12):4526-4533. doi: 10.1210/jc.2017-01211.

Abstract

Context: Fibroblast growth factor 23 (FGF23) plays an important role in phosphate homeostasis, but its regulation is inadequately characterized.

Objective: To examine FGF23 regulators, especially sex and iron status, in early childhood.

Design: A cross-sectional study involving 1-year-old children.

Setting and participants: Healthy term infants with a birth weight appropriate for gestational age were recruited to an ongoing vitamin D trial at Kätilöopisto Maternity Hospital, Helsinki, Finland. At 12-month follow-up visits, serum FGF23, 25-hydroxyvitamin D (25OHD), phosphate, ionized calcium, parathyroid hormone, and iron status were measured. All 721 children (51% girls) with complete data were included.

Main outcome measures: Intact and C-terminal FGF23 concentrations and iron status at 1 year of age.

Results: Intact FGF23 was greater in girls than in boys [median, 44.4 pg/mL; interquartile range (IQR), 36.8 to 51.9; median, 40.9 pg/mL; IQR, 34.5 to 49.0, respectively; P < 0.001]. C-terminal FGF23 was similar in boys and girls (median, 2.8 pmol/L; IQR, 2.1 to 3.7; median, 2.9 pmol/L; IQR, 2.2 to 3.7, respectively; P = 0.393). The iron concentration was positively associated with intact FGF23 and was the strongest modifier of intact FGF23 (regression coefficient, 0.498; 95% confidence interval, 0.333 to 0.663; P < 0.001) with ferritin, season, ionized calcium, 25OHD, and sex as other covariates. The association between iron and C-terminal FGF23 was inversely related (regression coefficient, -0.072; 95% confidence interval, -0.092 to -0.051; P < 0.001).

Conclusions: At 1 year of age, FGF23 status was different in girls and boys, with intact FGF23 concentrations higher in girls. Iron modified FGF23 concentrations, with intact FGF23 higher and C-terminal lower, in those with greater iron concentrations.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Cross-Sectional Studies
  • Double-Blind Method
  • Female
  • Fibroblast Growth Factor-23
  • Fibroblast Growth Factors / blood*
  • Hormones / blood
  • Humans
  • Infant
  • Iron / blood
  • Iron, Dietary / pharmacology*
  • Male
  • Sex Characteristics

Substances

  • FGF23 protein, human
  • Hormones
  • Iron, Dietary
  • Fibroblast Growth Factors
  • Fibroblast Growth Factor-23
  • Iron